Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity

Cell Metab. 2022 Oct 4;34(10):1486-1498.e7. doi: 10.1016/j.cmet.2022.09.007.

Abstract

Late eating has been linked to obesity risk. It is unclear whether this is caused by changes in hunger and appetite, energy expenditure, or both, and whether molecular pathways in adipose tissues are involved. Therefore, we conducted a randomized, controlled, crossover trial (ClinicalTrials.gov NCT02298790) to determine the effects of late versus early eating while rigorously controlling for nutrient intake, physical activity, sleep, and light exposure. Late eating increased hunger (p < 0.0001) and altered appetite-regulating hormones, increasing waketime and 24-h ghrelin:leptin ratio (p < 0.0001 and p = 0.006, respectively). Furthermore, late eating decreased waketime energy expenditure (p = 0.002) and 24-h core body temperature (p = 0.019). Adipose tissue gene expression analyses showed that late eating altered pathways involved in lipid metabolism, e.g., p38 MAPK signaling, TGF-β signaling, modulation of receptor tyrosine kinases, and autophagy, in a direction consistent with decreased lipolysis/increased adipogenesis. These findings show converging mechanisms by which late eating may result in positive energy balance and increased obesity risk.

Keywords: adipose; early eating; energy expenditure; energy intake; gene expression; ghrelin; hunger; late eating; leptin; meal timing.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Appetite
  • Eating / physiology
  • Energy Intake
  • Energy Metabolism / physiology
  • Ghrelin / metabolism
  • Humans
  • Hunger* / physiology
  • Leptin / metabolism
  • Metabolic Networks and Pathways
  • Obesity / metabolism
  • Overweight*
  • Transforming Growth Factor beta / metabolism
  • Tyrosine / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Ghrelin
  • Leptin
  • Transforming Growth Factor beta
  • Tyrosine
  • p38 Mitogen-Activated Protein Kinases

Associated data

  • ClinicalTrials.gov/NCT02298790